Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma

Background and objective: Systemic treatments involving immunotherapy-tyrosine kinase inhibitor (IO-TKI) combinations and TKI monotherapy have significantly improved outcomes for patients with metastatic clear-cell renal cell carcinoma (mccRCC). However, there are no biomarkers for predicting the ef...

Description complète

Détails bibliographiques

Auteurs principaux:	Honglei Cui, Jie Wu, Gan Du, Linjun Hu, Xin Dong, Wang Qu, Hongsong Bai, Bingqing Shang, Ruiyang Xie, Hongzhe Shi, Youyan Guan, Xingang Bi, Changling Li, Jianhui Ma, Aiping Zhou, Jianzhong Shou
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-12-01
Collection:	European Urology Open Science
Sujets:	Immunoglobulin G Metastatic clear-cell renal cell carcinoma Prognosis Tyrosine kinase inhibitor Immunotherapy Combination therapy
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666168324010905
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!